In-house roundup: German injunction reform; fintech partnership challenges; plausibility data conundrums

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: German injunction reform; fintech partnership challenges; plausibility data conundrums

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses on German injunctions, fintech partnerships and plausibility conundrums

Drugs

German injunction reform: end injunction gap first say patent holders

Siemens, Nokia, the VDMA and others weigh in on government talks around automatic injunctions and agree that more judges and perhaps a lower hurdle to stay infringement proceedings are needed at the Federal Patent Court. Read more... 

Pharma companies uncertain on data needed for plausibility claims

Drug company lawyers say it is tricky determining the right kind and amount of data to support a claim because courts and examiners have different expectations of sufficiency to determine plausibility. Read more... 

Fintech partnership surge exacerbates negotiation and trade secret challenges

In-house counsel at MasterCard, American Express, MIAX and elsewhere explain how their growing number of fintech partnerships is affecting negotiations and increasing the risk of trade secret and patent litigation. Read more... 

Sign up to receive more content like this in Patent Strategy’s weekly newsletter.



more from across site and SHARED ros bottom lb

More from across our site

The tie-up could result in the firm’s German and France-based teams, which both have strong UPC expertise, becoming independent
News of a slowdown in the UK’s clean energy IP landscape and an EPO report on unitary patent uptake were also among the top talking points
Price hikes at ‘big law’ firms are pushing some clients toward boutiques that offer predictable fees, specialised expertise, and a model built around prioritising IP
The Australian side, in particular, can benefit by capitalising on its independent status to bring in more work from Western countries while still working with its former Chinese partner
Koen Bijvank of Brinkhof and Johannes Heselberger of Bardehle Pagenberg discuss the Amgen v Sanofi case and why it will be cited frequently
View the official winners of the 2025 Social Impact EMEA Awards
King & Wood Mallesons will break into two entities, 14 years after a merger between a Chinese and an Australian firm created the combined outfit
Teams from Shakespeare Martineau and DWF will take centre stage in a dispute concerning the registrability of dairy terminology in plant-based products
Senem Kayahan, attorney and founder at PatentSe, discusses how she divides prosecution tasks, and reveals the importance of empathetic client advice
The association’s Australian group has filed a formal complaint against the choice of venue, citing Dubai as an unsafe environment for the LGBTQIA+ community
Gift this article